Everolimus-Eluting Bioabsorbable-Polymer DES Outcomes: SYNERGY Update - Dean Kereiakes, MD, FACC, FSCAI

↳ This is a section part of Moment: CRT 2016 Technology & Innovation - Biodegradable Polymer DES Programs

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$5.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Everolimus-Eluting Bioabsorbable-Polymer DES Outcomes: SYNERGY Update presented by Dean Kereiakes, MD, FACC, FSCAI at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$5.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows

Session Name: Biodegradable Polymer DES Programs

Track: Technology & Innovation

Learning Objectives

  • Update in advances with bioresorbable & DCB technologies in interventional procedures

Other Components in this Moment

Overview
Do the Clinical Data Support the Use of DES with Biodegradable Polymers over DES with Durable Polymers? - Robert Byrne, MB BCh, PhD
Everolimus-Eluting Bioabsorbable-Polymer DES Outcomes: SYNERGY Update - Dean Kereiakes, MD, FACC, FSCAI
EXCELLA Novolimus Elution from PLLA Polymer-Coated Stents - Stefan Verheye, MD, PhD
Orsiro: PLLA/Sirolimus Biodegradable: The BIOFLOW Studies Indepth - Thomas Pilgrim, MD
Combo: A Combination of Sirolimus-Eluting Biodegradable Polymer and Anti-CD34 Antibody Coated Stent - Mitchell Krucoff, MD, FSCAI
Emerging Programs of DES with Biodegradable Polymers - Ricardo Costa, PhD
Loading Simple Education